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2INTRODUCTION
Highly active antiretroviral therapy (HAART) during pregnancy and breastfeeding significantly 
reduces vertical HIV transmission relative to short-course antiretroviral regimens.1-4
The rationale for HAART for the pregnant woman’s own health, to greatly improve her survival and 
avoid maternal orphanhood is equally compelling,5, 6 but has received much less attention.7 There is 
increasing concern about whether or not women diagnosed with HIV in pregnancy-related services 
access long-term HIV care and treatment services, but little is known about the factors affecting this.
In Kenya, we quantified client attrition along the pathway between testing HIV-positive in antenatal 
or delivery services (collectively ‘pregnancy-related services’) and accessing HIV-related services. We
assessed factors associated with uptake of HIV-related services in order to inform the design of 
interventions to minimize client drop-out.
METHODS
Setting
This study was carried out at the two government hospitals in Naivasha district, Rift Valley province, 
Kenya. 
According to Kenyan guidelines, all women attending pregnancy-related services with unknown HIV 
status or who most recently tested HIV-negative more than three months previously should be 
offered provider-initiated HIV testing and counselling as standard care.8 Rapid HIV tests are used and 
antiretroviral drugs are provided free of charge to those who require them. 
The 2008-09 Demographic Health Survey in Kenya found that 92% of pregnant women had received 
antenatal care (ANC) from a medical professional.9 Fifty-six percent of women who attended ANC
3were reported to have been counselled about HIV, tested, and received the results during ANC.9
National HIV prevalence among women aged 15-49 in 2007 was 8.8%.10
Kenya has been a pioneer for many prevention of mother-to-child transmission (PMTCT) of HIV
policies in Africa. National guidelines issued in 2005 already recommended lifelong HAART for 
pregnant women with a CD4 count <350 cells/mm3. 11 For pregnant women with a CD4 count >350 
cells/mm3, a triple combination of short-course antiretroviral therapy for PMTCT has been 
recommended since 2009.12 As elsewhere, however, the success of these policies is dependent on 
the health system being able to deliver the recommended interventions. 
There was a mean of 260 new antenatal clients per month and 400 deliveries per month at Naivasha 
District Hospital in the first 6 months of 2010. Gilgil Sub-District Hospital reported approximately 110 
new antenatal clients and 80 deliveries per month. HIV prevalence among antenatal women was 
about 4% in Naivasha and 6% in Gilgil during this period. 
In each hospital, every weekday, one nurse was responsible for HIV counselling and testing in ANC
before assisting with other maternal and child health services. All women who tested HIV-positive 
within pregnancy-related services should have been immediately referred to the HIV clinic. Both 
hospitals have an on-site HIV clinic; in Naivasha hospital it is situated within two minutes’ walk of
ANC, while in Gilgil it is a 5-10 minute walk away. 
Registration at the HIV clinic cost KShs20 ($0.23) and KShs100 ($1.15), and CD4 count testing cost 
KShs170 ($1.95) and KShs120 ($1.38) in Naivasha and Gilgil hospitals respectively.
These facilities constitute a convenience sample of hospitals selected because they were 
government hospitals without high levels of external support.
Methods
4A retrospective review of routine hospital data was carried out in two hospitals to construct a 
retrospective cohort of women diagnosed with HIV in the context of pregnancy and to assess their 
uptake of HIV-related services. The cohort included all women aged 15 and above who were 
recorded as having been diagnosed with HIV in pregnancy-related services between 1st January 2008 
and 30th June 2010.  
Each woman was given a unique study number to enable analysis of her recorded use of services 
across different hospital visits and clinical departments. A ‘matching’ algorithm was devised based 
on ANC numbers, hospital visit dates and available demographic information (name, age, location of 
residence and gestational age) to identify and link data on repeat-attendees within pregnancy-
related services as well as to assess uptake of services at the HIV clinic. The matching algorithm was 
validated using a sub-set of women enrolled in a prospective cohort study in Naivasha hospital for 
whom information on uptake of services was available. It was found to correctly match 97% of 
women across different hospital visits. For women who attended the HIV clinic, their patient files 
were reviewed to record uptake of CD4 count testing and HAART. All data were entered into Epi-
Data 3.1 (The EpiData Association, Odense, Denmark) and analysed in Stata 10.1 (Statacorp, TX, 
USA).
Using six months of follow-up time per woman, starting from her earliest recorded visit to 
pregnancy-related services during the study period, uptake of HIV-related services was quantified for 
each hospital. Fisher’s exact tests were used to assess differences between the hospitals.
Based on a priori hypotheses, univariable logistic regression was carried out to assess associations 
between available information and uptake of HIV-related services. Multivariable logistic regression 
analyses were carried out using all variables with a p-value ≤0.10 in the univariable analyses. 
Variables not associated with the outcome in the multivariable model were removed in a stepwise 
manner so that the final model only included variables associated with registration at the HIV clinic
(p≤0.10).  Despite its potential to over-estimate effect sizes, a stepwise approach was adopted to 
5improve coverage of the model in the context of large amounts of missing data for some variables. 
Due to missing data, all univariable analyses were re-run restricted to participants with no missing 
data. Study participants included in the final multivariable models were restricted to those for whom 
there were no missing data for the variables in the model. 
Kaplan-Meier survival analysis and a log-rank test for equality of survivor functions were carried out 
to assess time between HIV diagnosis and registration at the HIV clinic, and any differences in this 
between hospitals. 
Relevant policies and guidelines were consulted and hospital processes relevant to the pathway 
between HIV testing in pregnancy-related services and the HIV clinic were observed in 2009-2010 to 
identify where practice differed from policy. 
Ethical approval for this work was provided by the University of Nairobi Kenyatta National Hospital 
Ethics Review Committee and the London School of Hygiene & Tropical Medicine Ethics Committee. 
To preserve confidentiality, all files and databases were password-protected and, following matching 
and the assignment of unique study numbers, all personal identifiers were removed from active files.
RESULTS
Cohort characteristics
892 women in Naivasha hospital and 237 women in Gilgil hospital were recorded as having been 
diagnosed with HIV in pregnancy-related services in the study timeframe. Available demographic 
information relating to these women is presented in Table 1.
6Table 1: Characteristics of women who tested HIV-positive in pregnancy-related services, Jan 2008-
June 2010.
Naivasha Hospital Gilgil Hospital
n=892 n=237
Year of first recorded hospital visit
2008
2009
2010
Total with data
377 (42.3%)
362 (40.6%)
153 (17.2%)
892
110 (46.4%)
91 (38.4%)
36 (15.2%)
237
Age
15 – 19
20 – 24
25 – 29
30 – 44
Total with data
58 ( 7.4%)
259 (33.2%)
250 (32.1%)
213 (27.3%)
780
18 (7.7%)
78 (33.3%)
69 (29.5%)
69 (29.5%)
234
Marital status
Married
Widowed
Divorced
Single
Separated
Total with data
589 (86.0%)
11 (1.6%)
26 (3.8%)
52 (7.6%)
7 (1.0%)
685
179 (78.9%)
2 (0.9%)
16 (7.1%)
28 (12.3%)
2 (0.9%)
227
Number of pregnancies                 
1
2
3
4+
Total with data
125 (19.8%)
209 (32.0%)
164 (25.9%)
135 (21.3%)
633
45 (19.9%)
68 (30.1%)
62 (27.4%)
51 (22.6%)
226
Gestational age*
8-21 weeks
22-27 weeks
28 – 34 weeks
34-39 weeks
Total with data
55 (17.0%)
91 (28.1%)
111 (34.3%)
67 (20.7%)
324
30 (17.5%)
43 (25.2%)
59 (34.5%)
39 (22.8%)
171
Distance
<15 mins walk from home to clinic
>15 mins walk or having to pay for transport
Total with data
363 (56.2%)
283 (43.8%)
646
108 (49.3%)
111 (50.7%)
219
MCH register where woman 1st appeared
ANC
Delivery
Total with data
395 (44.3%)
497 (55.7%)
892
205 (86.5%)
32 (13.5%)
237
* Analysis restricted to visits that are noted in the antenatal register to be first visits for the current 
pregnancy.
In Naivasha, more women were married, lived nearer to the hospital and only attended the hospital 
for delivery services (i.e. if they attended ANC at all it was at a different health facility) than in Gilgil. 
7There were a lot of data missing from the registers, especially from the delivery register in Naivasha. 
As 56% of study participants at Naivasha hospital had only attended for delivery, this affected a large 
proportion of the study participants. 
Processes for linking women into long-term HIV care and treatment services
Observation in the study hospitals found that although there was a policy of nurses escorting women 
diagnosed with HIV in pregnancy-related services to the HIV clinic in both hospitals, in practice, 
staffing constraints sometimes prevented this. On first contact at the HIV clinic in Gilgil hospital, 
women were registered and referred to the laboratory (situated adjacent to the HIV clinic) for a 
blood-draw for their CD4 count. In Naivasha this was less systematic, with some women not 
registered for HIV care until the result of their CD4 count test was available, which could have been 
at their third HIV clinic visit.
The PMTCT Cascade
Figure 1 shows client attrition between testing HIV-positive in pregnancy-related services and 
accessing HIV-related services in the study hospitals. 
8At Naivasha hospital, the proportion of women who registered at the HIV clinic within six months 
was 17.2% (153/892) while at Gilgil hospital it was 35.4% (84/237; p<0.001). There was additional 
high drop-out after the initial visit to the HIV clinic. Uptake of CD4 count testing was also sub-
optimal: 99/153 (68%) and 36/84 (43%) in Naivasha and Gilgil, respectively. A high proportion of 
women for whom a CD4 count was available were eligible for immediate HAART but uptake of 
HAART among these women was low at 40% in Naivasha and 27% in Gilgil. 
9Factors associated with registration at the HIV clinic
Data from the two hospitals were analysed separately due to the differences in attendance patterns 
and processes for linking women into HIV care.
Univariable logistic regression analyses assessing factors associated with registration at the HIV clinic 
within six months of HIV diagnosis in pregnancy-related services are presented in Table 2.
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Table 2: Factors associated with successful registration at the HIV clinic within six months of HIV diagnosis in 
pregnancy-related services.
Naivasha District Hospital Gilgil Sub-District Hospital
Description Registered
(row %)
UnAdjOR* 95%CI Registered
(row %)
UnAdjOR* 95%CI
Year of 1st recorded 
visit
P<0.001 P=0.032
2008 47/377 (12.5) 1.00 35/110 (31.8) 1.00
2009 55/362 (15.2) 1.26 0.83, 1.91 41/91 (45.1) 1.76 0.99, 3.13
2010 51/153 (33.3) 3.51 2.23, 5.52 8/36 (22.2) 0.61 0.25, 1.48
Age P=0.680 P=0.836
15-19
20-24
9/58 (15.5)
54/259 (20.9)
1.00
1.43 0.66, 3.10
8/18 (44.4)
29/78 (37.2)
1.00
0.74 0.26, 2.09
25-29
30-44
52/250 (20.8)
38/213 (17.8)
1.42
1.18
0.66, 3.10
0.54, 2.61
24/69 (34.8)
23/69 (33.3)
0.67
0.63
0.23, 1.91
0.22, 1.80
Marital status P=0.432 P=0.444
Married 109/589 (18.5) 1.00 67/179 (37.4) 1.00
Single
Separated
Divorced
Widowed
11/52 (21.2)
0/7 (0.0)
2/26 (7.7)
3/11 (27.3)
1.18
0.56
0.59, 2.37
0.22, 1.47
12/28 (42.9)
0/2 (0.0)
3/16 (18.8)
2/2 (100.0)
1.25
0.56
0.56, 2.81
0..19, 1.60
Distance from home to 
hospital
P=0.186 P=0.482
<15 mins walk 78/363 (21.5) 1.00 35/108 (32.4) 1.00
>15 mins walk or 
having to pay for 
transport
49/283 (17.3) 0.77 0.51, 1.13 41/111 (36.9) 1.22 0.70, 2.13
Timing of 1st antenatal 
visit
P=0.951 P=0.953
8-21 weeks gestation 
24-27 weeks gestation
16/55 (29.1)
23/91 (25.3)
1.00
0.82 0.39, 1.74
10/30 (33.3)
15/43 (34.9)
1.00
1.07 0.40, 2.87
28-34 weeks gestation
35-39 weeks gestation
28/111 (25.2)
17/67 (25.4)
0.82
0.83
0.40, 1.69
0.37, 1.85
23/59 (39.0)
14/39 (35.9)
1.28
1.12
0.51, 3.21
0.41, 3.05
MCH register where 
woman 1st appeared
P<0.001 P=0.189
Delivery 49/497 (9.9) 1.00 8/32 (25.0) 1.00
Antenatal care 104/395 (26.3) 3.27 0.21, 0.44 76/205 (37.1) 1.77 0.24, 1.32
No. of pregnancies 
(including current one)
P=0.450 P=0.007
One 19/125 (15.2) 1.00 25/45 (55.6) 1.00
Two
Three
Four +
41/209 (19.6)
34/164 (20.7)
21/135 (15.6)
1.36
1.46
1.03
0.75, 2.47
0.79, 2.70
0.52, 2.02
16/68 (23.5)
23/62 (37.1)
16/51 (31.4)
0.25
0.47
0.37
0.11, 0.55
0.22, 1.03
0.16, 0.84
Number of pregnancy-
related visits 
P<0.001 P=0.004
One visit 75/664 (11.3) 1.00 32/124 (25.8) 1.00
Two visits 61/153 (39.9) 5.21 3.48, 7.79 27/63 (42.9) 2.16 1.14, 4.09
Three or more visits 17/75 (22.7) 2.30 1.27, 4.16 25/50 (50.0) 2.88 1.45, 5.70
Receipt of both 
maternal and infant 
prophylaxis
P=0.009 P=0.370
No 59/430 (13.7) 1.00 28/88 (31.8) 1.00
Yes 94/462 (20.4) 1.61 1.13, 2.29 56/149 (37.6) 1.29 0.74, 2.25
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* p-values for heterogeneity based on likelihood ratio test
In both hospitals, linkage into HIV care was lower among women who first appeared in the delivery
register rather than the ANC register; in Naivasha this was particularly marked (9.9% vs. 26.3%; 
p<0.001). Linkage into care was lowest among women who only attended pregnancy-related
services once, many of whom, in Naivasha, only attended for delivery. 
Just over half of the study participants received both maternal and infant prophylaxis: 462/892 
(51.8%) in Naivasha and 149/237 (62.9%) in Gilgil.  There was a suggestion of an association at both 
hospitals between receiving both maternal and infant prophylaxis and registering at the HIV clinic 
within 6 months, particularly in Naivasha where 20.4% of women who had received both prophylaxis 
registered at the HIV clinic vs. 13.7% of women who did not receive both prophylaxis (p=0.009). 
Associations with the other factors measured differed between the study hospitals. In Naivasha, 
registration improved over the study period from 12.5% in 2008 to 33.3% in 2010, but this was not 
the case in Gilgil. There was no evidence of a linear trend in HIV clinic registration over time in either 
hospital (likelihood ratio test for departure from linear trend: p=0.031 in Naivasha and p=0.075 in 
Gilgil). In Gilgil women in their first pregnancy were more likely to register than women in 
subsequent pregnancies. 
Re-running the univariable analyses restricted to participants with no missing data (n=533), the only 
variable for which the result differed substantively was living far from the clinic (OR:0.77; p=0.184 
changed to OR:0.67; p-value=0.074).  Due to the volume of missing data this was not included in the 
multivariable model. 
In univariable analysis, there was no significant association between registration at the HIV clinic 
within six months of diagnosis and age, marital status, distance from the hospital, or gestational age 
at first ANC visit at either hospital.
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Different factors were included in the multivariable logistic regression models for each hospital 
(Table 3). 
Table 3: Multivariable logistic regression model assessing factors associated with registration at the HIV clinic 
within six months of HIV diagnosis in pregnancy-related services.
Naivasha Hospital
N=892
Gilgil Hospital
N=226
n AdjOR 95%CI n AdjOR 95%CI
Year of 1st recorded hospital visit* p<0.001 P=0.028
2008 377 1.00 110 1.00
2009 362 1.22 0.79, 1.89 84 1.92 1.03, 3.58
2010 153 3.94 2.43, 6.38 32 0.62 0.23,1.65
Number of pregnancy-related 
visits 
P<0.001 P=0.001
One 664 1.00 113 1.00
Two+ 228 3.37 2.06, 5.54 113 2.83 1.56, 5.14
MCH register where woman 1st
appeared
p=0.081
Delivery 497 1.00
Antenatal care 395 1.56 0.95, 2.57
No. of pregnancies (including 
current pregnancy)
P=0.001
One 45 3.42 1.67, 6.98
Two+ 181 1.00
* Likelihood ratio test for departure from a linear trend: p=0.012 for Naivasha hospital and p=0.008 
for Gilgil hospital i.e. there is no evidence of a linear trend over time in either hospital
In Naivasha, only year of first recorded hospital visit, attendance at multiple pregnancy-related visits 
and appearing in the hospital’s ANC register were associated with registration at the HIV clinic. In 
Gilgil, year and attendance at multiple pregnancy-related visits were also associated with the 
outcome but attendance at Gilgil hospital’s ANC services was not. Women in their first pregnancy 
were three times more likely to register at the HIV clinic than women in a subsequent pregnancy in 
Gilgil.
Time to registration at the HIV clinic
Time to registration at the HIV clinic was analysed separately for each hospital (Figure 2).
Figure 2: Time between HIV diagnosis in pregnancy-related services and registration at the HIV clinic
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Time-to-registration was shorter at Gilgil hospital than at Naivasha hospital (p<0.001). Around one-
quarter of women registered at the HIV clinic immediately following their HIV diagnosis in Gilgil,
while this proportion was much lower in Naivasha. After this initial difference, registration at the HIV 
clinic followed a similar pattern in the two hospitals of very gradual additional uptake of services 
over the six-month period. 
DISCUSSION
Of all the women diagnosed with HIV in pregnancy-related services, only 17% and 35% in Naivasha 
and Gilgil, respectively, registered at the HIV clinic within six months of diagnosis. Of particular 
interest was the low level of registration at the HIV clinic among women who had only attended 
pregnancy-related services once at the study hospital and, in Naivasha, women who had only 
attended for delivery. This may be partly explained by the high levels of migrant labour in Naivasha 
and women’s propensity to mobility around the time of delivery. It highlights the challenges in 
providing longitudinal care services for mobile populations. Naivasha hospital is a referral facility for 
a large catchment area so women travel long distances to access services there. Such women may 
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have been unlikely to initiate chronic care in Naivasha if these services were available closer to 
where they lived, implying a potential need for attention to referrals to a broader selection of HIV 
clinics from delivery services, according to each woman’s needs.
This study could only trace women from pregnancy-related services to HIV services in the same 
hospital and would therefore under-estimate successful linkage into care if women sought HIV 
services at a different health facility. A prospective study carried out at Naivasha Hospital in 2010 
found that 13% of women diagnosed with HIV in pregnancy-related services accessed HIV-related 
services at an HIV clinic outside Naivasha Hospital (Ferguson et al, unpublished data). If it is assumed 
that the same proportion of women in these retrospective cohorts sought HIV care and treatment 
outside the study hospitals, 30% (268/892) and 48% (114/237) of women from Naivasha and Gilgil, 
respectively might have registered at an HIV clinic. However, until mid-2009 there were very few HIV 
clinics in the study area, and this remained the case for Gilgil throughout the study period suggesting 
that there were few alternative clinics where women could have sought care.
Four recent studies in sub-Saharan Africa found higher linkage into HIV-related services than this 
study: 62%-85% of women diagnosed with HIV in the context of pregnancy registered at the HIV 
clinic.13-16 In this study, additional attrition along the pathway to HAART resulted in only 40% and 
27% of known HAART-eligible women in Naivasha and Gilgil respectively actually initiating HAART 
within six months of their HIV diagnosis. This is in line with previous studies. Nine studies in sub-
Saharan Africa documented initiation of HAART among 12%-95% of women diagnosed with HIV in 
pregnancy-related services and known to be HAART-eligible.13-15, 17-22
Individual factors associated with uptake of services
In both of the study hospitals, women who attended multiple pregnancy-related appointments were
more likely to register at the HIV clinic: better compliance with the schedule of ANC visits might 
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suggest better care-seeking behaviour in general or the nurses could have used each visit as an
opportunity to link women to the HIV clinic. 
In Gilgil hospital, women in their first pregnancy were more likely to register at the HIV clinic than 
women in subsequent pregnancies, perhaps because many women in their first pregnancy are 
particularly nervous about their health and may be more likely to follow any advice given by health 
workers. This was not, however, the case in Naivasha hospital.
Given that previous research has highlighted transport costs and long travel times as barriers to 
accessing pregnancy-related and HIV-related services23-27, the lack of association between the 
distance between the woman’s home and the hospital and registration at the HIV clinic is striking. 
Data on this variable were missing for 23% of the women in the study; excluding all participants with 
missing data, possible evidence of an association was found (p=0.074). Had data on this variable 
been more complete, stronger evidence for an association may have been found.
Health systems factors associated with uptake of services
The proximity of pregnancy-related services and the HIV clinic in Naivasha hospital, when compared 
with Gilgil hospital, did not lead to higher registration at the HIV clinic. If client escorts were more 
frequent in Gilgil than Naivasha this might help explain this difference. In addition, according to 
national policies, registration at the HIV clinic should occur on first contact with the clinic. In 
Naivasha hospital, up to three visits could be required before registration, with staff reporting that it 
was “often not worth registering someone during their first visit as many women never returned to 
the clinic”, which might partially explain the particularly low rate of same-day registration in 
Naivasha.
Beyond escorting clients, there was no mechanism in either hospital for nurses in pregnancy-related 
services to know whether or not women they had referred to the HIV clinic ever registered there, or 
for nurses in the HIV clinic to know when women had been referred to their clinic from pregnancy-
16
related services. Hospitals with computer networks could set up tracking systems to enable follow-
up at repeat visits to pregnancy-related services. In other settings regular meetings between health 
workers in these departments could be established to try to track referral outcomes. This could be 
facilitated by using duplicate referral forms with one copy given to the client to take to the HIV clinic 
and the other copy retained within pregnancy-related services for reconciliation at the end of each 
month. 
It would seem critical that additional counselling be provided at the time of diagnosis and repeated 
during subsequent hospital visits to ensure that women have sufficient information to make 
informed decisions about using services. This is particularly pertinent to pregnant women who have 
received provider-initiated HIV testing and counselling as, having come to hospital to check on the 
state of their pregnancy and not to seek HIV testing, they may be less psychologically prepared for 
an HIV-positive diagnosis and the ensuing care requirements than clients who have sought voluntary 
counselling and testing.28
Although the PMTCT guidelines stipulate that counselling for HIV-positive pregnant women should 
include “information and skill on how to reduce or avoid MTCT”,8 none of the counselling messages 
given to women mentioned that HAART is the best PMTCT intervention for immuno-compromised 
women. As the primary focus of these women is often the health and wellbeing of their baby, this 
might be a useful strategy for promoting uptake of long-term HIV-related services.
Payments for registration at HIV-related services and for CD4 count tests in both hospitals likely 
contributed to the low levels of uptake. Costs of services have been identified as an important 
disincentive to accessing HIV-related services elsewhere.29, 30
The inaccessibility of CD4 count testing might also have constituted a barrier. At both hospitals
clients had to attend before 11am on one specific morning per week to have their blood drawn for a 
CD4 count. Even after the introduction of daily CD4 testing in Naivasha in January 2010, an 
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additional visit to the hospital for their CD4 count blood-draw was still required because women 
were unable to complete PMTCT services until after the 11am deadline at the HIV clinic. 
Making CD4 count testing free and feasible on the same day as HIV diagnosis might increase uptake 
and promote retention in care, especially for women who are still asymptomatic. This could be 
achieved through point-of-care CD4 testing. As an alternative, some facilities in Kenya use 
stabilization tubes (that enable prolonged storage of samples31) and draw blood for CD4 count 
testing at the time of diagnosis so the CD4 count result is available at the next hospital visit (Personal 
communication, J.Ong’ech. August 2011). 
Studies in other settings have shown that integrating CD4 count testing and initiation of HAART into 
antenatal services can facilitate women’s uptake of CD4 count testing and, if required, HAART during 
pregnancy.14, 21, 32 This should be considered wherever staffing and infrastructure allow. Other health 
system interventions designed to maximize retention in care for pregnant women with HIV have 
included: pregnant women bypassing queues at HIV services; paying trained staff to work overtime
so as to extend the hours of available services; task shifting; training new cadres of health workers 
such as lay counsellors to provide additional counselling to newly diagnosed clients; and peer escorts 
by women who have recently used PMTCT services.18, 33-35
Given the multiplicity of factors identified as affecting women’s pathways to care, a range of 
interventions within each hospital will be required to minimise attrition at different points along the 
PMTCT cascade. 
Limitations
This study is based on data from two government hospitals that do not constitute a representative 
sample of health facilities in Kenya. Although efforts were made to select hospitals without 
disproportionate external assistance e.g. from non-governmental organisations, the generalisability 
of these findings may be limited.
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The limitations of relying on routinely collected hospital data are well-known.36 There was a high 
proportion of missing data for certain variables, and there was the possibility of mis-recording of 
data. 
Conclusions
A striking level of attrition was identified between testing HIV-positive in pregnancy-related services 
and accessing HIV-related services in the study facilities. Only 4% of women estimated to need 
HAART in each hospital initiated HAART within six months of their HIV diagnosis. Women who only 
attended pregnancy-related services once had the lowest odds of registering at the HIV clinic 
highlighting the challenges associated with providing longitudinal care in the context of low uptake 
of services that may result from high population mobility. Innovation in service delivery is required 
to improve women’s access to services.
Further research is needed to better understand the broad range of factors affecting women’s 
decisions to access HIV-related services. These might include women’s experiences of health 
services, stigma related to an HIV diagnosis in pregnancy, levels of social support, and competing 
priorities.
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